Feasibility and outcomes of low‐dose and low‐frequency prophylaxis with recombinant extended half‐life products (Fc‐rFVIII and Fc‐rFIX) in Ivorian children with hemophilia: Two‐year experience in the setting of World Federation of Haemophilia humanitarian aid programme

Author:

Lambert Catherine1ORCID,Meité N'Dogomo2,Sanogo Ibrahima2,Lobet Sébastien134ORCID,Hermans Cedric1ORCID

Affiliation:

1. Hemostasis and Thrombosis Unit Division of Hematology Cliniques Universitaires Saint‐Luc Université Catholique de Louvain (UCLouvain) Brussels Belgium

2. Division of Clinical Hematology Centre Hospitalier Universitaire de Yopougon Abidjan Côte d’Ivoire

3. Secteur des Sciences de la Santé Institut de Recherche Expérimentale et Clinique Neuromusculoskeletal Lab (NMSK) Université Catholique de Louvain Brussels Belgium

4. Secteur de Kinésithérapie Cliniques Universitaires Saint‐Luc Brussels Belgium

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Reference25 articles.

1. WFH Guidelines for the Management of Hemophilia, 3rd edition

2. Prophylaxis in haemophilia should be life‐long;Makris M;Blood Transfus,2012

3. Modern treatment of haemophilia;Berntorp E;Bull World Health Organ,1995

4. The cost of severe haemophilia in Europe: the CHESS study;O'Hara J;Orphanet J Rare Dis,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3